Forian (FORA) Competitors $1.98 +0.06 (+2.85%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FORA vs. OPRX, III, MXCT, OABI, TCX, PESI, RGP, RCMT, AHG, and EDHLShould you be buying Forian stock or one of its competitors? The main competitors of Forian include OptimizeRx (OPRX), Information Services Group (III), MaxCyte (MXCT), OmniAb (OABI), Tucows (TCX), Perma-Fix Environmental Services (PESI), Resources Connection (RGP), RCM Technologies (RCMT), Akso Health Group (AHG), and Everbright Digital (EDHL). These companies are all part of the "business services" industry. Forian vs. Its Competitors OptimizeRx Information Services Group MaxCyte OmniAb Tucows Perma-Fix Environmental Services Resources Connection RCM Technologies Akso Health Group Everbright Digital Forian (NASDAQ:FORA) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership. Do insiders & institutionals hold more shares of FORA or OPRX? 19.3% of Forian shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 34.3% of Forian shares are held by company insiders. Comparatively, 5.6% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts prefer FORA or OPRX? Forian currently has a consensus price target of $5.00, suggesting a potential upside of 151.89%. OptimizeRx has a consensus price target of $10.81, suggesting a potential downside of 23.61%. Given Forian's stronger consensus rating and higher probable upside, research analysts clearly believe Forian is more favorable than OptimizeRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Forian 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00OptimizeRx 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73 Does the media prefer FORA or OPRX? In the previous week, Forian had 1 more articles in the media than OptimizeRx. MarketBeat recorded 2 mentions for Forian and 1 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 1.42 beat Forian's score of 1.24 indicating that OptimizeRx is being referred to more favorably in the news media. Company Overall Sentiment Forian Positive OptimizeRx Positive Is FORA or OPRX more profitable? Forian has a net margin of 0.00% compared to OptimizeRx's net margin of -16.33%. Forian's return on equity of 0.00% beat OptimizeRx's return on equity.Company Net Margins Return on Equity Return on Assets ForianN/A N/A N/A OptimizeRx -16.33%-0.29%-0.20% Which has more volatility and risk, FORA or OPRX? Forian has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, OptimizeRx has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Which has preferable valuation & earnings, FORA or OPRX? Forian has higher earnings, but lower revenue than OptimizeRx. Forian is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioForian$22.33M2.77-$2.81M-$0.09-22.06OptimizeRx$94.37M2.77-$18.66M-$0.84-16.85 SummaryForian beats OptimizeRx on 9 of the 16 factors compared between the two stocks. Get Forian News Delivered to You Automatically Sign up to receive the latest news and ratings for FORA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FORA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FORA vs. The Competition Export to ExcelMetricForianHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$61.94M$225.59M$5.57B$9.32BDividend YieldN/A5.90%4.23%4.03%P/E Ratio-22.06399.3828.6419.75Price / Sales2.77221.50432.34182.50Price / CashN/A47.1436.0257.96Price / BookN/A5.268.235.67Net Income-$2.81M-$15.55M$3.24B$257.98M7 Day Performance-8.10%-0.01%0.05%0.56%1 Month Performance-1.24%-0.29%5.65%8.88%1 Year Performance-23.36%11.05%26.57%14.24% Forian Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FORAForian2.458 of 5 stars$1.99+2.8%$5.00+151.9%-23.4%$61.94M$22.33M-22.06140News CoveragePositive NewsOPRXOptimizeRx2.0066 of 5 stars$13.05-2.8%$10.81-17.1%+26.0%$248.39M$92.13M-15.54100IIIInformation Services Group3.811 of 5 stars$5.00-2.2%$5.50+10.0%+45.3%$246.32M$247.59M33.331,323News CoverageHigh Trading VolumeMXCTMaxCyte2.9058 of 5 stars$2.17-2.7%$7.50+245.6%-55.1%$237.84M$38.63M-5.4280News CoverageOABIOmniAb3.0186 of 5 stars$1.87-3.1%$7.00+274.3%-57.7%$235.72M$26.74M-3.227News CoveragePositive NewsGap UpTCXTucows1.1231 of 5 stars$20.55+0.1%N/A-1.1%$226.89M$369.43M-2.231,000PESIPerma-Fix Environmental Services0.1573 of 5 stars$11.27+1.8%N/A+12.6%$204.27M$59.12M-9.02290News CoveragePositive NewsRGPResources Connection1.7635 of 5 stars$5.94-1.5%$5.00-15.8%-48.9%$199.41M$632.80M-1.813,376Upcoming EarningsRCMTRCM Technologies2.8657 of 5 stars$27.00+3.9%$33.50+24.1%+26.9%$192.35M$278.38M15.613,140High Trading VolumeAHGAkso Health Group0.4029 of 5 stars$1.19-3.7%N/A+46.9%$179.24M$2.41M0.0040Positive NewsGap UpEDHLEverbright DigitalN/A$6.08-1.0%N/AN/A$163.69MN/A0.007News CoverageHigh Trading Volume Related Companies and Tools Related Companies OptimizeRx Alternatives Information Services Group Alternatives MaxCyte Alternatives OmniAb Alternatives Tucows Alternatives Perma-Fix Environmental Services Alternatives Resources Connection Alternatives RCM Technologies Alternatives Akso Health Group Alternatives Everbright Digital Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FORA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forian Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forian With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
